m-PEG-NHS ester (MW 2000) is employed to modify active molecules, enhancing their antigenicity and immunogenicity, thereby aiding in the preparation of injectable formulations. Its modification of the serine protease lumbrokinase (LK) does not compromise its fibrinolytic and thrombolytic activities, indicating significant potential for application.